Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
AstraZeneca
Cipla
Harvard Business School
Merck
Queensland Health
Colorcon
Chinese Patent Office
Cantor Fitzgerald

Generated: June 22, 2018

DrugPatentWatch Database Preview

HYDROCHLOROTHIAZIDE; RESERPINE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for hydrochlorothiazide; reserpine and what is the scope of hydrochlorothiazide; reserpine patent protection?

Hydrochlorothiazide; reserpine
is the generic ingredient in eleven branded drugs marketed by Whiteworth Town Plsn, Abc Holding, Sandoz, Ivax Sub Teva Pharms, Pharmeral, Roxane, Watson Labs, Merck, Barr, West Ward, and Novartis, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for hydrochlorothiazide; reserpine.
Summary for HYDROCHLOROTHIAZIDE; RESERPINE
Synonyms for HYDROCHLOROTHIAZIDE; RESERPINE
C33H40N2O9.C7H8ClN3O4S2
H.R.-50
HYDRO-SERP "25"
HYDRO-SERP "50"
HYDROCHLOROTHIAZIDE W/ RESERPINE
LS-178646
RESERPINE AND HYDROCHLOROTHIAZIDE
RESERPINE AND HYDROCHLOROTHIAZIDE-50
SCHEMBL4265419

US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE; RESERPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz RESERPINE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; reserpine TABLET;ORAL 088200-001 Jan 31, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmeral HYDROCHLOROTHIAZIDE W/ RESERPINE hydrochlorothiazide; reserpine TABLET;ORAL 085420-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs HYDROCHLOROTHIAZIDE W/ RESERPINE hydrochlorothiazide; reserpine TABLET;ORAL 084467-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ivax Sub Teva Pharms HYDROCHLOROTHIAZIDE W/ RESERPINE hydrochlorothiazide; reserpine TABLET;ORAL 083573-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Merck
Moodys
Colorcon
Argus Health
US Department of Justice
Daiichi Sankyo
Federal Trade Commission
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.